(PRWEB) September 15, 2017
Dr. Todd H. Lanman, founder of Beverly Hills’ Lanman Spinal Neurosurgery, and one of the world’s top innovators in the advancement of spinal health for more than 25 years, will return to The Congress of Neurological Surgeons’ Annual Meeting next month to speak to medical and industry peers on the topic of Artificial Disc Replacement, it has been announced today.
Lanman will present his findings regarding the new technology of the Artificial Cervical Disc Replacement procedure using an M6 cervical disc device. He will be sharing his analysis based upon comparing seven-year results of the one-level disc replacement to that of the two-level disc replacement and fusion.
Dr. Lanman will also be discussing Artificial Disc Replacement in the neck, or cervical spine, which is currently FDA approved for one and two levels. The purpose of his analysis was to review the results of one-level disc replacement and compare it to that of two-level disc replacement. He then compared both one and two level disc replacement against the control group, which were fusions, to see which groups fared better.
The Congress of Neurological Surgeons’ 2017 Annual Meeting will take place at the Boston Convention & Exhibition Center (415 Summer St.) in Boston, Massachusetts from October 7-11.
Dr. Lanman’s presentation will take place on October 10 at 3:05 pm.
The CNS Annual Meeting is the foremost assemblage and forum of those within the spinal health community presenting the opportunity to learn about the advancement in technologies in the field, cutting-edge procedures and approaches. This year’s theme is “Transformation & Celebration,” which challenges traditional ways of thinking and celebrates the wealth of achievements of neurosurgeons, like Dr. Lanman, around the world.
As a specialist in the advancement of spine surgery for nearly three decades, Dr. Lanman recently launched The Lanman Foundation for Spinal Advancement and Innovative Health (http://www.LanmanFoundation.com), his new charitable endeavor concentrates on innovation within spine health and further advancement of motion preserving spinal technologies, as well as helping United States military vets who have been injured during active duty and have had difficulties getting proper care.
He also acted as the Principal Investigator overseeing the 10-year clinical trial starting in 2006, leading to what has become the now FDA-approved two-level Artificial Cervical Disc Replacement procedure using the Prestige LP device.
Lanman Spinal Neurosurgery is affiliated with Cedars-Sinai Medical Center’s Institute for Spinal Disorders, UCLA Medical Center and Saint John’s Medical Center.